Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Целиакия: клинические особенности
Целиакия: клинические особенности
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol 1997; 136: 315–31.
2. Van der Meer JB. Granular deposits of immunoglobulins in the skin of patients with dermatitis herpetiformis. An immunofluorescent study. Br J Dermatol 1969; 81: 493–503.
3. Porter WM, Unsworth DJ, Lock RJ et al. Tissue transglutaminase antibodies in dermatitis herpetiformis. Gastroenterology 1999; 117: 749–50.
4. Collin P, Kaukinen K, Välimäki M et al. Endocrinological Disorders and Celiac Disease. Endocrine Reviews 2002; 23 (4): 464–83.
5. Ревнова М.О. Целиакия у детей – новый взгляд на старую проблему. РМЖ. 2008; 16 (18): 1209–12.
6. Saukkonen T, Savilahti E, Reijonen H et al. Coeliac disease: frequent occurrence after clinical onset of insulin-dependent diabetes mellitus. Diabet Med 1996; 13: 464–70.
7. Cacciari E, Bianchi FB, Salardi S et al. Late development of IgA antiendomycial antibodies and small intestinal mucosal atrophy after insulin dependent diabetes mellitus onset. Arch Dis Child 1997; 77: 465.
8. Lorini R, Scotta MS, Cortona L et al. Celiac disease and type I (insulin-dependent) diabetes mellitus in childhood: follow-up study. J Diabetes Complications 1996; 10: 154–9.
9. Valentino R, Savastano S, Maglio M et al. Markers of potential coeliac disease in patients with Hashimoto’s thyroiditis. Eur J Endocrinol 2002; 146: 479–83.
10. O’Leary C, Walsh CH, Wieneke P et al. Celiac disease and autoimmune Addison’s disease: a clinical pitfall. Q J Med 1995: 79–82.
11. Williams AJK, Norcross AJ, Lock RJ et al. The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity. Diabetes Care 2001; 24: 504–9.
12. Dalton TA, Bennett JC. Autoimmune disease and the major histocompatibility complex: therapeutic implications. Am J Med 1992; 92: 183–8.
13. Weetman AP, McGregor AM. Autoimmune thyroid disease: fur-ther developments in our understanding. Endocr Rev 1994; 15: 788–830.
14. Heward JM, Allahabadia A, Armitage M et al. The development of Graves’ disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab 1999; 84: 2398–401.
15. Da Rosa Utiyama SR, da Silva Kotze LM, Nisihara RM et al. Spectrum of autoantibodies in celiac patients and relatives. Dig Dis Sci 2001; 46: 2624–30.
16. Gomis R, Sener A, Malaisse-Lagae F, Malaisse WJ. Transglutaminase activity in pancreatic islets. Biochim Biophys Acta 1983; 760: 384–8.
17. Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 2004; 20 (7): 769–75. PMID: 15379837.
2. Van der Meer JB. Granular deposits of immunoglobulins in the skin of patients with dermatitis herpetiformis. An immunofluorescent study. Br J Dermatol 1969; 81: 493–503.
3. Porter WM, Unsworth DJ, Lock RJ et al. Tissue transglutaminase antibodies in dermatitis herpetiformis. Gastroenterology 1999; 117: 749–50.
4. Collin P, Kaukinen K, Välimäki M et al. Endocrinological Disorders and Celiac Disease. Endocrine Reviews 2002; 23 (4): 464–83.
5. Ревнова М.О. Целиакия у детей – новый взгляд на старую проблему. РМЖ. 2008; 16 (18): 1209–12.
6. Saukkonen T, Savilahti E, Reijonen H et al. Coeliac disease: frequent occurrence after clinical onset of insulin-dependent diabetes mellitus. Diabet Med 1996; 13: 464–70.
7. Cacciari E, Bianchi FB, Salardi S et al. Late development of IgA antiendomycial antibodies and small intestinal mucosal atrophy after insulin dependent diabetes mellitus onset. Arch Dis Child 1997; 77: 465.
8. Lorini R, Scotta MS, Cortona L et al. Celiac disease and type I (insulin-dependent) diabetes mellitus in childhood: follow-up study. J Diabetes Complications 1996; 10: 154–9.
9. Valentino R, Savastano S, Maglio M et al. Markers of potential coeliac disease in patients with Hashimoto’s thyroiditis. Eur J Endocrinol 2002; 146: 479–83.
10. O’Leary C, Walsh CH, Wieneke P et al. Celiac disease and autoimmune Addison’s disease: a clinical pitfall. Q J Med 1995: 79–82.
11. Williams AJK, Norcross AJ, Lock RJ et al. The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity. Diabetes Care 2001; 24: 504–9.
12. Dalton TA, Bennett JC. Autoimmune disease and the major histocompatibility complex: therapeutic implications. Am J Med 1992; 92: 183–8.
13. Weetman AP, McGregor AM. Autoimmune thyroid disease: fur-ther developments in our understanding. Endocr Rev 1994; 15: 788–830.
14. Heward JM, Allahabadia A, Armitage M et al. The development of Graves’ disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab 1999; 84: 2398–401.
15. Da Rosa Utiyama SR, da Silva Kotze LM, Nisihara RM et al. Spectrum of autoantibodies in celiac patients and relatives. Dig Dis Sci 2001; 46: 2624–30.
16. Gomis R, Sener A, Malaisse-Lagae F, Malaisse WJ. Transglutaminase activity in pancreatic islets. Biochim Biophys Acta 1983; 760: 384–8.
17. Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 2004; 20 (7): 769–75. PMID: 15379837.
Авторы
И.Н.Захарова1, Т.Э.Боровик2, 3, Е.А.Рославцева3, Ю.А.Дмитриева1, Е.Н.Касаткина1, В.А.Курьянинова1, Ф.С.Дзебисова1
1 ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава России, Москва;
2 ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава России, Москва;
3 ФГБУ Научный центр здоровья детей РАМН, Москва
1 ГБОУ ДПО Российская медицинская академия последипломного образования Минздрава России, Москва;
2 ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава России, Москва;
3 ФГБУ Научный центр здоровья детей РАМН, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.